PharmaCyte Biotech Inc (PMCB) News & Events

$0.515

-0.024 (-4.66%)At close

PMCB News

9.511-26Benzinga

Autodesk Shares Rise Approximately 6%; 20 Stocks Making Moves in Premarket Trading

7.511-25Newsfilter

PharmaCyte Monetizes Femasys Stake, Boosts Cash to $20 Million

8.509-02Newsfilter

PharmaCyte Biotech, Inc. Expands Investment in TNF Pharmaceuticals Following New License for Innovative Light Speed Computing Platform for Cryptocurrency Use

8.508-18Newsfilter

PharmaCyte Biotech, Inc. Secures $7 Million in Funding from Current Investors

7.0Newsfilter

NT 10-K Form - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - PharmaCyte Biotech, Inc. (0001157075) (Filer)

1.0Newsfilter

8-K Form - Current report, item 5.07 - PharmaCyte Biotech, Inc. (0001157075) (Filer)

Show More News

PMCB Events

12/31 08:50

Sellas Life Sciences Borrow Rate Increases to 534.91%

Latest data shows the largest indicative borrow rate increases among liquid option names include: Sellas Life Sciences (SLS) 534.91% +52.88, Cipher Mining (CIFR) 4.04% +3.56, PharmaCyte Biotech (PMCB) 90.49% +2.80, Kodiak AI, Inc. Common Stock (KDK) 58.74% +2.64, Vuzix (VUZI) 48.34% +1.93, Starfighters Space, Inc. (FJET) 429.26% +1.51, Tidal Trust II (IRE) 26.79% +0.89, T-REX 2X Long BMNR Daily Target ETF (BMNU) 41.01% +0.77, BTQ Technologies Corp. Common Stock (BTQ) 59.99% +0.23, and Gorilla Technology Group Inc (GRRR) 8.76% +0.22.

12/30 08:50

PharmaCyte Biotech Borrow Rate Hits 96.86% Among Liquid Options

Latest data shows the largest indicative borrow rate increases among liquid option names include: PharmaCyte Biotech (PMCB) 96.86% +3.59, BTQ Technologies Corp. Common Stock (BTQ) 64.68% +2.49, Reviva Pharmaceuticals Holdings (RVPH) 32.53% +0.76, Intuitive Machines Inc (LUNR) 1.14% +0.67, Eightco Holdings Inc (ORBS) 83.67% +0.63, Bilibili (BILI) 2.23% +0.46, Talphera Inc (TLPH) 4.98% +0.33, Outlook Therapeutics Inc (OTLK) 8.56% +0.27, GRANITESHARES 2X LONG MARA DAILY ETF (MRAL) 33.55% +0.24, and ProShares Short VIX Short Term Futures (SVXY) 1.87% +0.21.

12/29 08:50

BigBearai Holdings Borrow Rate Increases to 13.64%

Latest data shows the largest indicative borrow rate increases among liquid option names include: BigBearai Holdings (BBAI) 13.64% +9.54, Sellas Life Sciences (SLS) 67.67% +9.53, T-REX 2X LONG MSTR DAILY TARGET (MSTU) 50.84% +6.40, WhiteFiber Inc (WYFI) 17.02% +4.88, New Fortress Energy (NFE) 156.18% +4.70, PharmaCyte Biotech (PMCB) 94.30% +4.45, Kyivstar Group Ltd. Common Shares (KYIV) 40.58% +0.85, Sealsq Corp (LAES) 74.36% +0.74, GRANITESHARES 2X LONG MARA DAILY ETF (MRAL) 34.08% +0.54, and Irobot Corporation (IRBTQ) 114.76% +0.53.

12/15 08:50

PharmaCyte Biotech Borrow Rate Increases to 279.47% Among Liquid Options

Latest data shows the largest indicative borrow rate increases among liquid option names include: PharmaCyte Biotech (PMCB) 279.47% +3.85, Nano Nuclear Energy Inc (NNE) 76.92% +3.32, Itau Unibanco (ITUB) 4.11% +1.32, Gold Bear 3x (DUST) 8.14% +0.73, Reviva Pharmaceuticals Holdings (RVPH) 35.24% +0.41, Cambium Networks (CMBM) 88.85% +0.39, Advisorshares Pure Us Cannabis ETF (MSOS) 0.89% +0.36, Yieldmax TSLA Income ETF (TSLY) 7.83% +0.35, STMicroelectronics (STM) 1.03% +0.30, and SPDR S&P Metals and Mining (XME) 1.74% +0.27.

11/25 09:23

PharmaCyte divests Femasys shares, anticipates cash reserves increasing to $20M

PharmaCyte Biotech (PMCB) announced the successful monetization of its stake in Femasys (FEMY). Following the monetization of the stake, PharmaCyte's cash and marketable securities are expected to increase to approximately $20M, up from $13.3M as of July 31.

Show More Events

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.